Showing results (1161-1170 of 2,125) with videos related to
Sort By:
Pageof 213
Journal of Ovarian Research|March 12, 2025
Gengnianchun formula ameliorates insulin resistance-induced diminished ovarian reserve via the estrogen signaling pathway: evidence from network pharmacology and experimental validationYanqiu Rao, Jun Li, Ting Xu, et al.Journal of Ovarian Research|March 8, 2025
Link between iron-mediated lipid peroxidation and polycystic ovary syndrome (PCOS): exploring the genes underlying iron regulatory mechanismNighat Hayat, Zertashia Akram, Nayab Khalid, et al.Journal of Ovarian Research|March 13, 2025
Follicular metabolic dysfunction, oocyte aneuploidy and ovarian aging: a reviewDie Wu, Chuanming Liu, Lijun DingJournal of Ovarian Research|December 20, 2024
Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysisLijun Lin, Ge Chen, Xiaoyong Qiao, et al.Journal of Ovarian Research|December 5, 2024
Exploring the innovative application of cerium oxide nanoparticles for addressing oxidative stress in ovarian tissue regenerationMaya Lakshmanan, Monika Saini, Manasa NuneJournal of Ovarian Research|November 27, 2024
Unraveling the complexity of follicular fluid: insights into its composition, function, and clinical implicationsYurong Pan, Chenyu Pan, Chunping ZhangJournal of Ovarian Research|December 20, 2024
Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K/Akt/mTOR signaling pathway and Yap-1Negin Zatalian, Azam Dalman, Parvaneh Afsharian, et al.Journal of Ovarian Research|December 20, 2024
Bile acids in follicular fluid: potential new therapeutic targets and predictive markers for women with diminished ovarian reserveShu Ding, Wenyan Li, Xianglei Xiong, et al.Journal of Ovarian Research|December 20, 2024
Scutellaria barbata D.Don and Hedyotis diffusa Willd herb pair combined with cisplatin synergistically inhibits ovarian cancer progression through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathwayXue Sui, Bingqing Gao, Liu Zhang, et al.Journal of Ovarian Research|November 12, 2024
MSCs-derived EVs protect against chemotherapy-induced ovarian toxicity: role of PI3K/AKT/mTOR axisNehal M Elsherbiny, Mohamed S Abdel-Maksoud, Kousalya Prabahar, et al.Pageof 213